Abolis Biotechnologies
Created in 2014
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
6,425Activities
Technologies
Entity types
Location
20 Rue Henri Auguste Desbruères, 91000 Évry-Courcouronnes, France
Évry-Courcouronnes
France
Employees
Scale: 51-200
Estimated: 42
SIREN
801679614Engaged corporates
11
1 11Added in Motherbase
3 years, 1 month ago
biotech Value proposition
Decipher - Innovate - Build
Abolis is a French company developing high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms.
Founded in 2014, Abolis is made up of a team of over 50 people, sharing a scientific and humanist ambition. Determined to become a key player in the ecological transition, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals.
We help industries make the ecological transition by rethinking their production models
We rely on biotechnologies and the untapped potential of micro-organisms to develop new bioproduction solutions that are economically and ecologically sustainable alternatives to petrochemical products and chemical ingredients.
We take up the industry's current challenges by:
· Using renewable raw materials
· Relocate essential production and secure supply chains
· Designing biocompatible products less toxic for the environment
· Reducing greenhouse gas emissions
Abolis is providing tailor-made industrial solutions, based on microorganisms
Because each customer has its own unique story and challenges, we cultivate a multidisciplinary, tailor-made approach. Science, economics, intellectual property, industrial realities: each of our answers is based on the best possible practices. Thanks to our advanced knowledge of micro-organisms, we combine chemistry and biology, paving the way for a more sustainable future.
We are...
independent in thought and action
rigorous in our approach and the way we work
creative because we never stop innovating, while remaining pragmatic
ambitious because we are passionate and determined to make a difference
Synthetic Biology, Metabolic engineering, Pathway engineering, Molecular biology, Metabolic modeling, Fine chemicals, Performance chemicals, Bioinformatics, nutrition, healthcare, and cosmeticsOriginal language
Decipher - Innovate - Build
Abolis is a French company developing high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms.
Founded in 2014, Abolis is made up of a team of over 50 people, sharing a scientific and humanist ambition. Determined to become a key player in the ecological transition, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals.
We help industries make the ecological transition by rethinking their production models
We rely on biotechnologies and the untapped potential of micro-organisms to develop new bioproduction solutions that are economically and ecologically sustainable alternatives to petrochemical products and chemical ingredients.
We take up the industry's current challenges by:
· Using renewable raw materials
· Relocate essential production and secure supply chains
· Designing biocompatible products less toxic for the environment
· Reducing greenhouse gas emissions
Abolis is providing tailor-made industrial solutions, based on microorganisms
Because each customer has its own unique story and challenges, we cultivate a multidisciplinary, tailor-made approach. Science, economics, intellectual property, industrial realities: each of our answers is based on the best possible practices. Thanks to our advanced knowledge of micro-organisms, we combine chemistry and biology, paving the way for a more sustainable future.
We are...
independent in thought and action
rigorous in our approach and the way we work
creative because we never stop innovating, while remaining pragmatic
ambitious because we are passionate and determined to make a difference
Abolis, Bio-Synthesis Architects • Abolis
Abolis is an industrial biotechnology company. We are developing bio-production processes for chemical molecules by fermentation of biomass.
https://www.abolis.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Boston Consulting Group (BCG) Consulting, Business Consulting and Services | Boston Consulting Group (BCG) Consulting, Business Consulting and Services | Other 28 Feb 2024 | | |
 Mouvement Impact France Civic and Social Organizations | Mouvement Impact France Civic and Social Organizations | Other 23 Nov 2023 | | |
 France Digitale Startup accelerator & VC, Non-profit Organizations | France Digitale Startup accelerator & VC, Non-profit Organizations | Other 23 Nov 2023 | | |
 Direction Générale des Entreprises National and local authorities, Government Administration | Direction Générale des Entreprises National and local authorities, Government Administration | Other 3 Oct 2023 | | |
 ShakeUp Factory Venture Capital and Private Equity Principals | ShakeUp Factory Venture Capital and Private Equity Principals | Other 26 Apr 2023 | | |
 Groupe TF1 Media, Broadcast Media Production and Distribution | Groupe TF1 Media, Broadcast Media Production and Distribution | Other 26 Apr 2023 | | |
 STATION F Startup accelerator & VC, Software Development | STATION F Startup accelerator & VC, Software Development | Other 26 Apr 2023 | | |
 Hello Tomorrow Trade show, Business Consulting and Services | Hello Tomorrow Trade show, Business Consulting and Services | Other 12 Mar 2023 | | |
 Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Other 18 Jan 2023 | | |
 Genopole Biotechnology, Biotechnology Research | Genopole Biotechnology, Biotechnology Research | Other 19 May 2023 | | |